Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation (Q33470751)

27 July 2017

5 references

13 March 2019

19 June 2019

2 October 2019

17 November 2019

20 November 2019

0 references

Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation (English)

1 reference

27 July 2017

0 references

1 reference

2 October 2019

1 reference

17 November 2019

1 reference

20 November 2019

1 reference

Jaro Wex

1

1 reference

27 July 2017

Mark Connolly

series ordinal

2

1 reference

27 July 2017

Werner Rath

series ordinal

3

1 reference

27 July 2017

publication date

19 June 2009

6 references

BMC Pregnancy and Childbirth

27 July 2017

13 March 2019

19 June 2019

2 October 2019

17 November 2019

20 November 2019

6 references

27 July 2017

13 March 2019

19 June 2019

2 October 2019

17 November 2019

20 November 2019

9

1 reference

27 July 2017

page(s)

23

1 reference

Creative Commons Attribution 2.0 Generic

27 July 2017

copyright license

5 references

13 March 2019

19 June 2019

2 October 2019

17 November 2019

Prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies

20 November 2019

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Epidemiology and causes of preterm birth

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Clinical practice evaluation of atosiban in preterm labour management in six European countries

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Births: final data for 2004.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Development and validation of MIX: comprehensive free software for meta-analysis of causal research data

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Oxytocin receptor antagonists for inhibiting preterm labour

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Cyclo-oxygenase (COX) inhibitors for treating preterm labour

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Pharmacoeconomic assessment of two tocolysis protocols for the inhibition of premature delivery

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Betamimetics for inhibiting preterm labour

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Calcium channel blockers for inhibiting preterm labour

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Magnesium sulphate for preventing preterm birth in threatened preterm labour.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Treatment of preterm labor with the beta-adrenergic agonist ritodrine

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability

14 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-9-23

Neurologic and developmental disability after extremely preterm birth. EPICure Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-9-23

A cost decision analysis of 4 tocolytic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-9-23

Pragmatic comparison of beta2-agonist side effects within the Worldwide Atosiban versus Beta Agonists study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-9-23

Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-9-23

Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-9-23

Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-9-23

Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-9-23

Defining standards of care in maternal-fetal medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-9-23

Comparison of the cost of treatment of premature labor with atosiban or beta-sympathomimetics from the perspective of the health care payer--a pharmacoeconomic model

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2708127

Perinatal factors and preterm delivery in an Irish obstetric population

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19538754

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The prevention of perinatal mortality and morbidity. Report of a WHO Expert Committee

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19538754

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Atosiban versus usual care for the management of preterm labor

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19538754

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2393-9-23

1 reference

Dimensions Publication ID

27 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2393-9-23

9 September 2019

1 reference

27 July 2017

1 reference